Revolade (eltrombopag)

pCPA File Number: 20760
Negotiation Status:
Negotiations were not pursued
Indication(s):
Thrombocytopenia associated with chronic hepatitis c infection
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
SR0377-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: